GC1113: Clinical Trials

1 trial of GC1113, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow GC1113: new trials by email Literature Review of GC1113 trials Research Report on GC1113

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)
GX-E2, NESP, MIRCERA - Anemia, Chronic Kidney Disease
Phase 2CompletedGenexine, Inc.2572014-04-152017-10-16

Conditions studied

Anemia (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Genexine, Inc. (1)

Countries

South Korea (1)

Top investigators

Byung Chul Shin, MD (1)  ·  Chul-Woo Yang, MD (1)  ·  Eun Young Seong, MD (1)  ·  Hyung Wook Kim, MD (1)  ·  Ki Young Na, MD (1)  ·  Sangho Lee, MD (1)  ·  Seok Joon Shin, MD (1)  ·  Su-Hyun Kim, MD (1)  ·  Sug Kyun Shin, MD (1)  ·  Won Kim, MD (1)  ·  Yong-Lim Kim, MD (1)  ·  Young Sun Kang, MD (1)  ·  Young-il Jo, MD (1)